CellFE Announces Addition of Life Science Tools Veteran Mike Rice to Board of Directors
CellFE Appoints Mike Rice to Board of Directors
News
Categories
CellFE Announces Presentations at International Society of Gene & Cell Therapy (ISCT) 2024 Annual Meeting
CellFE announced today an upcoming presentation by CEO Alla Zamarayeva, PhD, at the International Society of Gene & Cell Therapy (ISCT) Annual Meeting, taking place May 29-June 1, 2024 in Vancouver, BC.
CellFE Announces May 2024 Conference Presentations
CellFE announced today an upcoming presentation by CSO Todd Sulchek, PhD, at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting, taking place May 7-11, 2024 in Baltimore, MD.
CellFE secures $22 million in Series A financing to advance microfluidics-based cellular engineering platform
CellFE announced the completion of a $22 million Series A financing led by M Ventures, with participation from Great Point Ventures, Riverine Ventures and its existing investors.
CellFE Closes Series Seed Funding Round
CellFE announced it has raised $3.6 million in an initial Series Seed, co-led by Cota Capital and Dynamk Capital, and joined by Embark Ventures.